Skip to content

Avantor AVTR Share Buybacks

Share Buybacks at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$3B+50.0%
Danaher logo
DanaherDHR
$0-100%
Agilent Technologies logo
Agilent TechnologiesA
$65M-60.6%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$297.6M+123%
Westlake logo
WestlakeWLK
$0-100%
NewMarket logo
NewMarketNEU

Other financials

Income statement

See full
Revenue$1.6B0.0%
Gross profit$500.7M-6.4%
Operating income$99.5M-32.5%
Net income$43.3M-32.9%
EPS (diluted)$0.06-33.3%

Balance sheet

See full
Cash & equivalents$282.2M-11.4%
Total debt$3.8B-7.1%
Total equity$5.6B-8.4%
Total assets$11.7B-5.4%

Cash flow

See full
Operating cash flow$58.7M-46.3%
CapEx$33.5M+19.6%
Free cash flow$25.2M-69.0%

Valuation

See full
Market cap$6.54B-52.0%
Enterprise value$10.07B-40.4%
P/S-1.0×

Profitability

See full
Gross margin32.1%-1.4pp
Operating margin4%-5.2pp
Net margin-9.2%-19.9pp
FCF margin6.7%-3.3pp

Returns & leverage

See full
Return on equity-10.3%-22.8pp
Debt / equity0.7×0.0×
Current ratio1.8×+0.6×

Where this comes from

Reported directly by Avantor in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: Avantor’s 10-K, filed February 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avantor's share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avantor's share buybacks?
Avantor (AVTR) reported share buybacks of $18.78M in Q4 2025.
What does share buybacks mean?
Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.